The Vox Markets Podcast Vox Markets Podcast
-
- Business
Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.
-
The Exchange with Richard Crow & Paul Hill
Live on today's Vox Markets Exchange, I was delighted again to speak to accomplished investor & expert stock picker Richard Crow (alias Cockney Rebel) – including:
00:00 His investment approach & YTD’24 returns
07:10 Possible market impact of the UK general election
13:50 CMC Markets
20:20 Funding Circle UK
28:25 TP ICAP
32:05 Liontrust Asset Management PLC
34:15 Reliability of a ‘Bowl’ chart
38:10 Halfords
41:35 RBG Holdings plc
45:20 Synthomer
55:30 Zotefoams
63:20 Warpaint Cosmetics
67:55 Mpac Group
73:45 Greencore
80:20 IG Design Group Plc
84:35 Luceco Group
90:35 Filtronic
#CMCX #FCH #TCAP #LIO #MPAC #GNC #IGR h#LUCE #SYNT #W7L #ZTF #RBGP #HFD #FTC -
Q&A with European Green Transition CEO, Aiden Lavelle
Aiden Lavelle joins to talk us through the latest news from the Olserum project in Scandinavia, and in particular the implications of the increased strike length and newly discovered structure there. He also talks about what it means for the upcoming drill programme, and how potential partners might be looking at the project now, in the light of the recent developments.
-
Rome Resources Explores High-Grade Tin Opportunities in the DRC
Grade is king and Rome Resources has got some of the best tin grades found anywhere in the world at its suite of assets in the Democratic Republic of Congo. Klaus Eckhoff, who's an old hand working in the DRC, joins us now to tell us about the opportunity on offer, as Rome joins Aim via a reverse takeover of the
Pathfinder Resources shell. -
Hvivo Q&A: “this contract is important as it opens up new markets”
Watch on YouTube
Vox Markets speaks to Mo Khan, CEO of clinical research specialist Hvivo, about a new $2.5 million contract for an Omicron variant study to determine the virus dose needed to infect vaccinated individuals. This study will facilitate future human challenge trials to test vaccines and antivirals, with significant developments expected in 2025, expanding H Vivo’s market opportunities. -
Growth Company Investor is back!
Vox Markets is now the proud new owner of esteemed small cap investing magazine Growth Company Investor, with Vox's Head of Content and former IC editor John Hughman and former GCI editor David Thornton providing regular ideas on underresearched companies. In this preview podcast, John and David discuss their investment philosphies and what to expect when GCI is relaunched next week.
-
Is Tesla a Fraud? The Case Against Elon Musk
Tesla is being investigated for securities and wire fraud for self-driving claims. Is Tesla a giant fraud on the scale of Theranos? Witness for the prosecution Mark Spiegel from Stanphyl Capital joins Neil to make the case against Elon Musk.
https://www.finalto.com/uk/overleveraged/
All opinions, news, research, analysis, prices or other information is provided as general market commentary and not as investment advice and all potential results discussed are not guaranteed to be achieved. The information may have been derived from publicly available sources, company reports, personal research, or surveys. Past performance is not indicative of future performance. Trading carries risk of capital loss. Service available to professional clients only.